Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibit... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status
0
Authors
Biagio Ricciuti
32 more
Biagio Ricciuti
•
Kathryn Arbour
30 more
•
Mark Awad
Published
November 3, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Thoracic Oncology
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.jtho.2021.10.013
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Thoracic Oncology
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.jtho.2021.10.013
License
publisher-specific-oa
